Document is current
Any future updates will be listed below
-
Authors
Gao, Lei
Ma, Sheng
Yan, Shu
Zhang, Hua
Tian, Ling
Li, Lize
Diao, Lei
Miao, Liyan
Yang, Xiaoran
Diao, Xingxing
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82373938)
Key Technologies R&D Program of Guangdong Province (2023B1111030004)
National Key Research and Development Program of China (2022YFF1202600)
- License Information
-
More Information
Article History
Received: 22 February 2025
Accepted: 3 May 2025
First Online: 26 May 2025
Change Date: 25 June 2025
Change Type: Update
Change Details: The original online version of this article was revised to update the first and last author affiliation details
Declarations
:
: Authors Xiaoran Yang, Ling Tian and Lize Li were employed by Liaoning Avanc Pharmaceutical Co., Ltd. Author Lei Dia was employed by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The authors declare no competing interests.
